Skip to Content

Maviret 50 mg / 20 mg coated granules in sachet

Licence status
Authorised: 21/06/2021
Active substances
Glecaprevir, Pibrentasvir
Dosage Form
Coated granules in sachet
Licence number
EU/1/17/1213/003
Licence holder
AbbVie Deutschland GmbH & Co. KG

Licence information

ATC code
J05A DIRECT ACTING ANTIVIRALS, J05AP57 glecaprevir and pibrentasvir
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
21/06/2021